Shorla Oncology
PrivateLast Round
VC Round
Jan 17, 2026
Total Funding Raised
$43.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shorla Oncology is a pharmaceutical company that develops and commercializes innovative oncology drugs, with a focus on orphan and pediatric cancers where existing treatments are limited or in short supply.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shorla Oncology Comparables
Compare Shorla Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eagle Pharmaceuticals, Inc. | 78% | |
| Amneal Pharmaceuticals, Inc. | 70% | |
| Therakind Ltd | 68% |
Shorla Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 17, 2026 | ||||
| Series B | Oct 4, 2023 | ||||
| Series A | Jun 3, 2020 |
Key People
Founding team and executive leadership
Shorla Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seroba Life Sciences | Series B, VC Round, Series A |
| Enterprise Ireland | Series B, VC Round, Series A |
| Kurma Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 41% MoM, from 1.8K to 2.6K.
- Jan 27, 2026
$21M round completed.
Shorla Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shorla Oncology's valuation, stock price, and market status.
Is Shorla Oncology a public or private company?
Shorla Oncology is a private company.
What is the current stock price of Shorla Oncology?
Shorla Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Shorla Oncology worth (valuation)?
Valuation information for Shorla Oncology is not publicly available.
Can I buy Shorla Oncology stock?
Shorla Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shorla Oncology's last funding round?
Shorla Oncology's most recent funding round was Series C on January 27, 2026.
Who are the main investors in Shorla Oncology?
Key investors in Shorla Oncology include Seroba Life Sciences, Kurma Partners.
Will Shorla Oncology IPO soon?
No public IPO plans have been announced for Shorla Oncology.
How can I track Shorla Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shorla Oncology's secondary market activity and sign up for updates.